This topic contains a solution. Click here to go to the answer

Author Question: Topical anesthesia should be left on the mucosa for how long to be most effective? a. 30 seconds b. ... (Read 66 times)

misspop

  • Hero Member
  • *****
  • Posts: 540
Topical anesthesia should be left on the mucosa for how long to be most effective?
 a. 30 seconds
  b. 60 seconds
  c. 2 minutes
  d. 5 minutes

Question 2

Using E-speed film instead of D-speed film will reduce the developing time.
 a. True
  b. False
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

apple

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

b
RATIONALE: Topical anesthesia should be left on the mucosa for 60 seconds to be most effective.

Answer to Question 2

False
RATIONALE: Using E-speed film instead of D-speed film will reduce the exposure time.




misspop

  • Member
  • Posts: 540
Reply 2 on: Jun 25, 2018
Gracias!


hollysheppard095

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library